Procter & Gamble and Church & Dwight join Jefferies' list of favorite household product stocks
Seeking Alpha News (Wed, 17-Dec 8:50 AM ET)
Jefferies Sticks to Its Hold Rating for Colgate-Palmolive (CL)
TipRanks (Tue, 16-Dec 6:25 PM ET)
The Week That Was, The Week Ahead: Macro & Markets, Dec. 14
TipRanks (Sun, 14-Dec 5:04 AM ET)
Colgate Declares Regular Quarterly Dividend
Business Wire (Wed, 10-Dec 4:35 PM ET)
Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Global Consumer & Retail Conference
Business Wire (Tue, 18-Nov 9:30 AM ET)
Colgate-Palmolive Company Announces 3rd Quarter 2025 Results
Business Wire (Fri, 31-Oct 6:55 AM ET)
Business Wire (Tue, 21-Oct 9:30 AM ET)
Has CL been a good buy before earnings?
Market Chameleon (Wed, 15-Oct 6:13 AM ET)
Should you buy CL stock before earnings?
Market Chameleon (Wed, 23-Jul 8:30 AM ET)
Here's what history shows about CL past earnings run-ups
Market Chameleon (Wed, 16-Apr 6:59 AM ET)
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of December 18, 2025, CL stock price declined to $77.73 with 9,078,435 million shares trading.
CL has a beta of 0.08, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.01 to the broad based SPY ETF.
CL has a market cap of $62.66 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.91 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.02.
In the last 3 years, CL traded as high as $109.30 and as low as $67.62.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, IVV, SPY, XLP.
CL has underperformed the market in the last year with a return of -14.7%, while the SPY ETF gained +13.1%. In the last 3 month period, CL fell short of the market, returning -4.8%, while SPY returned +2.9%. However, in the most recent 2 weeks CL has outperformed the stock market by returning -0.6%, while SPY returned -1.1%.
CL support price is $78.72 and resistance is $80.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL shares will trade within this expected range on the day.